XML 45 R25.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidating Financial Statements
12 Months Ended
Mar. 31, 2016
Condensed Financial Information of Parent Company Only Disclosure [Abstract]  
Condensed Consolidating Financial Statements
Condensed Consolidating Financial Statements
As discussed in Note 2, "Debt", the Company's 10.5% Senior Notes are fully and unconditionally guaranteed, jointly and severally, on a senior basis by certain of the Company's 100% owned domestic subsidiaries ("Guarantor Subsidiaries") and secured by a first priority lien on 51% of the capital stock of certain of the Company's foreign restricted subsidiaries ("Non-Guarantor Subsidiaries"). The Company's Guarantor Subsidiaries are not consistent with the Company's business groups or geographic operations; accordingly, this basis of presentation is not intended to present the Company's financial condition, results of operations or cash flows for any purpose other than to comply with the specific requirements for subsidiary guarantor reporting. We are required to present condensed consolidating financial information in order for the Guarantor Subsidiaries of the Company's public debt to be exempt from reporting under the Securities Exchange Act of 1934, as amended.
Condensed consolidating financial statements for the Company's Guarantor Subsidiaries and Non-Guarantor Subsidiaries are presented in the following tables (amounts in thousands):
Condensed Consolidating Balance Sheet
March 31, 2016
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
640

 
$
36,209

 
$
28,155

 
$

 
$
65,004

Accounts receivable, net
 

 
41,025

 
52,143

 

 
93,168

Intercompany receivable
 
30,210

 
132,523

 
170,224

 
(332,957
)
 

Inventories, net
 

 
113,289

 
55,590

 

 
168,879

Prepaid expenses and other
 
3,325

 
12,161

 
12,974

 
(2,964
)
 
25,496

Total current assets
 
34,175

 
335,207

 
319,086

 
(335,921
)
 
352,547

Property and equipment, net
 
255

 
93,936

 
147,648

 

 
241,839

Investments in NEC TOKIN
 

 
20,334

 

 

 
20,334

Investments in subsidiaries
 
382,108

 
429,723

 
93,359

 
(905,190
)
 

Goodwill
 

 
40,294

 

 

 
40,294

Intangible assets, net
 

 
27,252

 
6,049

 

 
33,301

Deferred income taxes
 

 
800

 
7,597

 

 
8,397

Other assets
 
2,764

 
2,452

 
616

 

 
5,832

Long-term intercompany receivable
 
67,500

 
41,428

 
1,088

 
(110,016
)
 

Total assets
 
$
486,802

 
$
991,426

 
$
575,443

 
$
(1,351,127
)
 
$
702,544

LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
 
$
2,000

 
$

 
$

 
$

 
$
2,000

Accounts payable, trade
 
20

 
34,618

 
36,343

 

 
70,981

Intercompany payable
 
280

 
275,498

 
57,179

 
(332,957
)
 

Accrued expenses
 
17,305

 
11,807

 
21,208

 

 
50,320

Income taxes payable
 

 
2,983

 
434

 
(2,964
)
 
453

Total current liabilities
 
19,605

 
324,906

 
115,164

 
(335,921
)
 
123,754

Long-term debt, less current portion
 
354,716

 
19,881

 
14,000

 

 
388,597

Other non-current obligations
 

 
25,797

 
49,095

 

 
74,892

Deferred income taxes
 

 
2,242

 
578

 

 
2,820

Long-term intercompany payable
 

 
67,500

 
42,516

 
(110,016
)
 

Stockholders' equity
 
112,481

 
551,100

 
354,090

 
(905,190
)
 
112,481

Total liabilities and stockholders' equity
 
$
486,802

 
$
991,426

 
$
575,443

 
$
(1,351,127
)
 
$
702,544


Condensed Consolidating Balance Sheet
March 31, 2015
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
640

 
$
33,094

 
$
22,628

 
$

 
$
56,362

Accounts receivable, net
 

 
35,535

 
55,322

 

 
90,857

Intercompany receivable
 
321,233

 
403,557

 
195,518

 
(920,308
)
 

Inventories, net
 

 
119,221

 
52,622

 

 
171,843

Prepaid expenses and other
 
3,191

 
21,134

 
20,164

 
(2,986
)
 
41,503

Total current assets
 
325,064

 
612,541

 
346,254

 
(923,294
)
 
360,565

Property and equipment, net
 
293

 
100,844

 
148,504

 

 
249,641

Investment in NEC TOKIN
 

 
45,016

 

 

 
45,016

Investment in subsidiaries
 
401,062

 
423,737

 
93,359

 
(918,158
)
 

Goodwill
 

 
35,584

 

 

 
35,584

Intangible assets, net
 

 
26,998

 
6,284

 

 
33,282

Restricted cash
 

 

 

 

 

Deferred income taxes
 

 
971

 
8,803

 

 
9,774

Other assets
 
4,088

 
7,824

 
919

 

 
12,831

Long-term intercompany receivable
 
63,788

 
39,151

 
1,088

 
(104,027
)
 

Total assets
 
$
794,295

 
$
1,292,666

 
$
605,211

 
$
(1,945,479
)
 
$
746,693

LIABILITIES AND STOCKHOLDERS' EQUITY
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
Current portion of long-term debt
 
$

 
$
500

 
$
462

 
$

 
$
962

Accounts payable, trade
 
47

 
36,565

 
33,173

 

 
69,785

Intercompany payable
 
254,852

 
578,318

 
87,138

 
(920,308
)
 

Accrued expenses
 
17,253

 
16,644

 
26,559

 

 
60,456

Income taxes payable
 

 
2,928

 
942

 
(2,986
)
 
884

Total current liabilities
 
272,152

 
634,955

 
148,274

 
(923,294
)
 
132,087

Long-term debt, less current portion
 
357,461

 
20,948

 
12,000

 

 
390,409

Other non-current obligations
 

 
2,987

 
54,144

 

 
57,131

Deferred income taxes
 

 
2,241

 
143

 

 
2,384

Long-term intercompany payable
 

 
63,789

 
40,238

 
(104,027
)
 

Stockholders' equity
 
164,682

 
567,746

 
350,412

 
(918,158
)
 
164,682

Total liabilities and stockholders' equity
 
$
794,295

 
$
1,292,666

 
$
605,211

 
$
(1,945,479
)
 
$
746,693


Condensed Consolidating Statements of Operations
Fiscal Year Ended March 31, 2016
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and
Eliminations
 
Consolidated
Net sales
 
$

 
$
866,163

 
$
703,690

 
$
(835,030
)
 
$
734,823

Operating costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
1,194

 
708,143

 
642,362

 
(780,156
)
 
571,543

Selling, general and administrative expenses
 
38,071

 
74,521

 
43,728

 
(54,874
)
 
101,446

Research and development
 
79

 
17,313

 
7,563

 

 
24,955

Restructuring charges
 

 
2,564

 
1,614

 

 
4,178

Net (gain) loss on sales and disposals of assets
 
(7
)
 
(484
)
 
866

 

 
375

Total operating costs and expenses
 
39,337

 
802,057

 
696,133

 
(835,030
)
 
702,497

Operating income (loss)
 
(39,337
)
 
64,106

 
7,557

 

 
32,326

Other (income) expense:
 
 
 
 
 
 
 
 
 
 
Interest income
 

 

 
(14
)
 

 
(14
)
Interest expense
 
37,856

 
1,189

 
560

 

 
39,605

Change in value of NEC TOKIN options
 

 
26,300

 

 

 
26,300

Non-operating (income) expense, net
 
(36,183
)
 
34,188

 
(353
)
 

 
(2,348
)
Equity in earnings of subsidiaries
 
12,619

 

 

 
(12,619
)
 

Income (loss) from continuing operations before income taxes and equity income (loss) from NEC TOKIN
 
(53,629
)
 
2,429

 
7,364

 
12,619

 
(31,217
)
Income tax expense (benefit)
 

 
(269
)
 
6,275

 

 
6,006

Income (loss) from continuing operations before equity income (loss) from NEC TOKIN
 
(53,629
)
 
2,698

 
1,089

 
12,619

 
(37,223
)
Equity income (loss) from NEC TOKIN
 

 
(16,406
)
 

 

 
(16,406
)
Income (loss) from continuing operations
 
(53,629
)
 
(13,708
)
 
1,089

 
12,619

 
(53,629
)
Income (loss) from discontinued operations
 

 

 

 

 

Net income (loss)
 
$
(53,629
)
 
$
(13,708
)
 
$
1,089

 
$
12,619

 
$
(53,629
)

Condensed Consolidating Statements of Comprehensive Income (Loss)
Fiscal Year Ended March 31, 2016
Other comprehensive income (loss)
 
$
(49,918
)
 
$
(24,832
)
 
$
5,873

 
$
12,619

 
$
(56,258
)

Condensed Consolidating Statements of Operations
Fiscal Year Ended March 31, 2015
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and
Eliminations
 
Consolidated
Net sales
 
$
195

 
$
978,705

 
$
773,504

 
$
(929,212
)
 
$
823,192

Operating costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
2,468

 
823,429

 
707,493

 
(869,707
)
 
663,683

Selling, general and administrative expenses
 
41,783

 
70,074

 
46,181

 
(59,505
)
 
98,533

Research and development
 
436

 
17,588

 
7,778

 

 
25,802

Restructuring charges
 

 
3,310

 
9,707

 

 
13,017

Net (gain) loss on sales and disposals of assets
 
(10
)
 
181

 
(392
)
 

 
(221
)
Total operating costs and expenses
 
44,677

 
914,582

 
770,767

 
(929,212
)
 
800,814

Operating income (loss)
 
(44,482
)
 
64,123

 
2,737

 

 
22,378

Other (income) expense:
 
 
 
 
 
 
 
 
 
 
Interest income
 

 

 
(15
)
 

 
(15
)
Interest expense
 
38,632

 
998

 
1,071

 

 
40,701

Change in value of NEC TOKIN options
 

 
(2,100
)
 

 

 
(2,100
)
Non-operating (income) expense, net
 
(40,903
)
 
49,069

 
(12,248
)
 

 
(4,082
)
Equity in earnings of subsidiaries
 
(27,998
)
 

 

 
27,998

 

Income (loss) from continuing operations before income taxes and equity income (loss) from NEC TOKIN
 
(14,213
)
 
16,156

 
13,929

 
(27,998
)
 
(12,126
)
Income tax expense (benefit)
 
(70
)
 
576

 
4,721

 

 
5,227

Income (loss) from continuing operations before equity income (loss) from NEC TOKIN 
 
(14,143
)
 
15,580

 
9,208

 
(27,998
)
 
(17,353
)
Equity income (loss) from NEC TOKIN
 

 
(2,169
)
 

 

 
(2,169
)
Income (loss) from continuing operations  
 
(14,143
)
 
13,411

 
9,208

 
(27,998
)
 
(19,522
)
Income (loss) from discontinued operations
 

 
102

 
5,277

 

 
5,379

Net income (loss)
 
$
(14,143
)
 
$
13,513

 
$
14,485

 
$
(27,998
)
 
$
(14,143
)

Condensed Consolidating Statements of Comprehensive Income (Loss)
Fiscal Year Ended March 31, 2015
Comprehensive income (loss)
 
$
(32,103
)
 
$
19,650

 
$
(20,672
)
 
$
(27,998
)
 
$
(61,123
)
Condensed Consolidating Statements of Operations
Fiscal Year Ended March 31, 2014
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and
Eliminations
 
Consolidated
Net sales
 
$
218

 
$
966,369

 
$
817,945

 
$
(950,866
)
 
$
833,666

Operating costs and expenses:
 
 
 
 
 
 
 
 
 
 
Cost of sales
 
1,336

 
878,308

 
729,105

 
(895,824
)
 
712,925

Selling, general and administrative expenses
 
41,359

 
61,896

 
47,643

 
(55,042
)
 
95,856

Research and development
 
229

 
16,849

 
7,388

 

 
24,466

Restructuring charges
 

 
2,858

 
11,264

 

 
14,122

Write down of long-lived assets
 

 
1,118

 
3,358

 

 
4,476

Net (gain) loss on sales and disposals of assets
 

 
(625
)
 
657

 

 
32

Net (gain) loss on intercompany asset transfer
 

 
14,564

 
(14,564
)
 

 

Total operating costs and expenses
 
42,924

 
974,968

 
784,851

 
(950,866
)
 
851,877

Operating income (loss)
 
(42,706
)
 
(8,599
)
 
33,094

 

 
(18,211
)
Other (income) expense:
 
 
 
 
 
 
 
 
 
 
Interest income
 
(12
)
 
(4
)
 
(179
)
 

 
(195
)
Interest expense
 
40,069

 
1,130

 
(237
)
 

 
40,962

Change in value of NEC TOKIN options
 

 
(3,111
)
 

 

 
(3,111
)
Other (income) expense, net
 
(40,642
)
 
39,852

 
1,220

 

 
430

Equity in earnings of subsidiaries
 
26,332

 

 

 
(26,332
)
 

Income (loss) from continuing operations before income taxes and equity income (loss) from NEC TOKIN
 
(68,453
)
 
(46,466
)
 
32,290

 
26,332

 
(56,297
)
Income tax expense (benefit)
 

 
(1,302
)
 
2,784

 

 
1,482

Income (loss) from continuing operations before equity income (loss) from NEC TOKIN  
 
(68,453
)
 
(45,164
)
 
29,506

 
26,332

 
(57,779
)
Equity income (loss) from NEC TOKIN
 

 
(7,090
)
 

 

 
(7,090
)
Income (loss) from continuing operations

    
 
(68,453
)
 
(52,254
)
 
29,506

 
26,332

 
(64,869
)
Income (loss) from discontinued operations
 
(50
)
 
(1,195
)
 
(2,389
)
 

 
(3,634
)
Net income (loss)
 
$
(68,503
)
 
$
(53,449
)
 
$
27,117

 
$
26,332

 
$
(68,503
)

Condensed Consolidating Statements of Comprehensive Income (Loss)
Fiscal Year Ended March 31, 2014
Comprehensive income (loss)
 
$
(62,676
)
 
$
(57,309
)
 
$
35,640

 
$
26,332

 
$
(58,013
)

Condensed Consolidating Statements of Cash Flows
Fiscal Year Ended March 31, 2016
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and
Eliminations
 
Consolidated
Sources (uses) of cash and cash equivalents
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
3,722

 
$
15,107

 
$
13,536

 
$

 
$
32,365

Investing activities:
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 

 
(9,550
)
 
(10,919
)
 

 
(20,469
)
Change in restricted cash
 

 
1,802

 

 

 
1,802

Proceeds from sale of assets
 

 
248

 
723

 

 
971

Acquisitions, net of cash received
 

 
(2,892
)
 

 

 
(2,892
)
Net cash provided by (used in) investing activities
 

 
(10,392
)
 
(10,196
)
 

 
(20,588
)
Financing activities:
 
 
 
 
 
 
 
 
 
 
Proceeds from revolving line of credit
 

 
8,000

 
2,000

 

 
10,000

Payments of revolving line of credit
 

 
(9,600
)
 

 

 
(9,600
)
Deferred acquisition payments
 
(3,000
)
 

 

 

 
(3,000
)
Payments of long-term debt
 

 

 
(481
)
 

 
(481
)
Proceeds from exercise of stock options
 

 

 

 

 

Purchase of treasury stock
 
(722
)
 

 

 

 
(722
)
Net cash provided by (used in) financing activities           
 
(3,722
)
 
(1,600
)
 
1,519

 

 
(3,803
)
Net increase (decrease) in cash and cash equivalents           
 

 
3,115

 
4,859

 

 
7,974

Effect of foreign currency fluctuations on cash
 

 

 
668

 

 
668

Cash and cash equivalents at beginning of fiscal year
 
640

 
33,094

 
22,628

 

 
56,362

Cash and cash equivalents at end of fiscal year
 
$
640

 
$
36,209

 
$
28,155

 
$

 
$
65,004


Condensed Consolidating Statements of Cash Flows
Fiscal Year Ended March 31, 2015
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and
Eliminations
 
Consolidated
Sources (uses) of cash and cash equivalents
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
39,575

 
$
(4,085
)
 
$
(11,088
)
 
$

 
$
24,402

Investing activities:
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 

 
(12,930
)
 
(9,302
)
 

 
(22,232
)
Change in restricted cash
 

 
11,509

 

 

 
11,509

Proceeds from sale of assets
 

 
2,403

 
2,385

 

 
4,788

Proceeds from sale of discontinued operations
 

 

 
9,564

 

 
9,564

Net cash provided by (used in) investing activities
 

 
982

 
2,647

 

 
3,629

Financing activities:
 
 
 
 
 
 
 
 
 
 
Proceeds from revolving line of credit
 

 
37,340

 
5,000

 

 
42,340

Payments on revolving line of credit
 

 
(22,342
)
 
(5,000
)
 

 
(27,342
)
Deferred acquisition payments
 
(18,527
)
 
(1,000
)
 

 

 
(19,527
)
Payments of long-term debt
 
(20,417
)
 

 
(1,316
)
 

 
(21,733
)
Proceeds from exercise of stock options
 
24

 

 

 

 
24

Purchase of treasury stock
 
(630
)
 

 

 

 
(630
)
Net cash provided by (used in) financing activities           
 
(39,550
)
 
13,998

 
(1,316
)
 

 
(26,868
)
Net increase (decrease) in cash and cash equivalents           
 
25

 
10,895

 
(9,757
)
 

 
1,163

Effect of foreign currency fluctuations on cash
 
(1
)
 
(1
)
 
(2,728
)
 

 
(2,730
)
Cash and cash equivalents at beginning of fiscal year
 
616

 
22,200

 
35,113

 

 
57,929

Cash and cash equivalents at end of fiscal year
 
$
640

 
$
33,094

 
$
22,628

 
$

 
$
56,362


Condensed Consolidating Statements of Cash Flows
Fiscal Year Ended March 31, 2014
 
 
Parent
 
Guarantor
Subsidiaries
 
Non-Guarantor
Subsidiaries
 
Reclassifications
and
Eliminations
 
Consolidated
Sources (uses) of cash and cash equivalents
 
 
 
 
 
 
 
 
 
 
Net cash provided by (used in) operating activities
 
$
7,724

 
$
(26,984
)
 
$
12,514

 
$

 
$
(6,746
)
Investing activities:
 
 
 
 
 
 
 
 
 
 
Capital expenditures
 

 
(13,348
)
 
(18,799
)
 

 
(32,147
)
Change in restricted cash
 

 
4,047

 

 

 
4,047

Proceeds from sale of assets
 

 
996

 
1,851

 

 
2,847

Net cash provided by (used in) investing activities
 

 
(8,305
)
 
(16,948
)
 

 
(25,253
)
Financing activities:
 
 
 
 
 
 
 
 
 
 
Proceeds from revolving line of credit
 

 
9,000

 
12,000

 

 
21,000

Payments on revolving line of credit
 

 
(2,551
)
 

 

 
(2,551
)
Deferred acquisition payments
 
(20,977
)
 
(1,000
)
 

 

 
(21,977
)
Payments of long-term debt
 
(3,583
)
 
(16
)
 

 

 
(3,599
)
Proceeds from exercise of stock options
 
250

 

 

 

 
250

Net cash provided by (used in) financing activities           
 
(24,310
)
 
5,433

 
12,000

 

 
(6,877
)
Net increase (decrease) in cash and cash equivalents           
 
(16,586
)
 
(29,856
)
 
7,566

 

 
(38,876
)
Effect of foreign currency fluctuations on cash
 

 

 
827

 

 
827

Cash and cash equivalents at beginning of fiscal year
 
17,202

 
52,056

 
26,720

 

 
95,978

Cash and cash equivalents at end of fiscal year
 
$
616

 
$
22,200

 
$
35,113

 
$

 
$
57,929